The Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases (RFA-CK-26-035) is a cooperative agreement offered by the Centers for Disease Control and Prevention (CDC). The programme supports research and surveillance to produce insights into disease detection, prevention strategies, burden, severity, diagnostics, treatment, and outcomes of infectious diseases in international travelers.
Timely surveillance and sentinel detection are essential for collecting actionable data. The research is expected to address public health questions that improve the speed of outbreak detection, help develop guidelines and recommendations to improve patient care, enhance understanding of the natural history of disease, optimize genomic surveillance and diagnostic and treatment strategies, and advance the global health security of the United States.
This funding opportunity comprises two components:
Applicants may apply for Component A, Component B, or both. If an application for both components is ranked top, Component B will be awarded.
The total estimated program funding is $30,000,000 over a performance period of five years (12-month budget periods). The award ceiling is $6,000,000 and the award floor is $1,750,000. Two awards are expected, one for each component, subject to available funds and program priorities.
Funding details per component per budget period:
The funding instrument is a cooperative agreement (activity code U01, assistance listing 93.084).
The following types of organizations are eligible to apply:
Each institution may submit only one application and must have its own Unique Entity Identifier (UEI). Applications that fail to meet all eligibility criteria, exceed the page limit or budget ceilings, do not clearly state the component(s) applied for, or are submitted after the deadline will not be considered.
Applicants must submit applications by 11:59 p.m. Eastern Time on November 5, 2026. A required letter of intent is due by September 15, 2025.
Prospective applicants should secure active registrations in SAM.gov (which can take several weeks) and Grants.gov (which can take several days) well in advance. A Login.gov registration is also required for Grants.gov.
The Research Strategy for each component must not exceed 12 pages. Applications must clearly delineate activities supporting Component A or Component B and state the component(s) applied for in the Specific Aims section.
Other key dates include the expected scientific review on December 15, 2026, secondary review on January 12, 2027, expected award date of August 2, 2027, and expected start date of September 1, 2027. The opportunity expires on December 7, 2026.
Scientific and Research
Brian York, Ph.D.
Scientific Program Officer
Phone: (404) 639-7094
Email: ryork@cdc.gov
Scientific Merit Review
Seraphine Pitt Barnes, PhD, MPH, CHES
Scientific Review Officer
Phone: (770) 488-6115
Email: SPittBarnes@cdc.gov
Grants Management
Sharon Cassell
Phone: (770) 488-2703
Email: ZPR0@cdc.gov
Help with Systems
Grants.gov: 1-800-518-4726 or support@grants.gov (24/7 support, closed federal holidays)
SAM.gov: 866-606-8220 or live chat with the Federal Service Desk
eRA Commons Help Desk: 301-402-7469 or 866-504-9552 (TTY 301-451-5939); email commons@od.nih.gov (Monday–Friday, 7 a.m. to 8 p.m. ET, closed federal holidays)
Analyze this opportunity instantly
Ensure you have all required documents before starting your application.
LOI Deadline
Sep 15, 2025
Submission Deadline
Nov 5, 2026
Review Period
Dec 15, 2026
Award Announcement
Aug 2, 2027
Project Start
Sep 1, 2027
Project Duration
60 Months
Collaboration
Multi-institutional
Questions about this grant?
Log in to create free customized alerts based on your prefernces